Effects of histone deacetylase inhibitors on amygdaloid histone acetylation and neuropeptide y expression: A role in anxiety-like and alcohol-drinking behaviours

International Journal of Neuropsychopharmacology

Volumn 17, Issue 8, 2014, Pages 1207-1220

  Sakharkar, Amul J ^a,b   Zhang, Huaibo ^a,b   Tang, Lei ^a,b   Baxstrom, Kathryn ^a,b   Shi, Guangbin ^a,b   Moonat, Sachin ^a,b   Pandey, Subhash C ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Jesse Brown VA   (United States)

Author keywords

Alcohol preference; amygdala; anxiety; HDAC inhibitors; histone acetylation; histone deacetylases; neuropeptide Y

Indexed keywords

HISTONE DEACETYLASE; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 4; HISTONE H3; NEUROPEPTIDE Y; TRICHOSTATIN A; ANXIOLYTIC AGENT; HISTONE; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID;

ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ANXIETY LIKE BEHAVIOUR; ARTICLE; ASTROCYTE; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; CYTOSOLIC FRACTION; DEACETYLATION; DRINKING BEHAVIOR; HISTONE ACETYLATION; MALE; MEDIAL AMYGDALA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; ACETYLATION; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; GENETIC EPIGENESIS; GENETICS; METABOLISM; PROTEIN PROCESSING;

ACETYLATION; ALCOHOL DRINKING; AMYGDALA; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; EPIGENESIS, GENETIC; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HISTONES; HYDROXAMIC ACIDS; MALE; NEUROPEPTIDE Y; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS;

EID: 84905968640     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145714000054     Document Type: Article

References (62)

1. Abel T, Zukin RS (2008) Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr Opin Pharmacol 8:57-64.
2. Arora DS, Nimitvilai S, Teppen TL, McElvain MA, Sakharkar AJ, You C, Pandey SC, Brodie MS (2013) Hyposensitivity to gamma-aminobutyric acid in the ventral tegmental area during alcohol withdrawal: reversal by histone deacetylase inhibitors. Neuropsychopharmacol 38:1674-1684.
3. Badia-Elder NE, Stewart RB, Powrozek TA, Roy KF, Murphy JM, Li T-K (2001) Effect of neuropeptide Y (NPY) on oral ethanol intake in Wistar, alcohol-preferring (P), and-non preferring (NP) rats. Alcohol Clin Exp Res 25:386-390.
4. Bell RL, Rodd ZA, Lumeng L, Murphy JM, McBride WJ (2006) The alcohol-preferring P rat and animal models of excessive alcohol drinking. Addict Biol 11:270-288.
5. Broide RS, Redwine JM, Aftahi N, Young W, Bloom FE, Winrow CJ (2007) Distribution of histone deacetylases 1-11 in the rat brain. J Mol Neurosci 31:47-58.
6. Cloninger CR (1987) Neurogenetic adaptive mechanisms in alcoholism. Science 236:410-416.
7. Covington III HE, Maze I, LaPlant QC, Vialou VF, Ohnishi YN, Berton O, Fass DM, Renthal W, Rush III AJ, Wu EY, Ghose S, Krishnan V, Russo SJ, Tamminga C, Haggarty SJ, Nestler EJ (2009) Antidepressant actions of histone deacetylase inhibitors. J Neurosci 29:11451-11460.
8. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB (2003) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 370:737-749.
9. Ding H, Dolan PJ, Johnson GV (2008) Histone deacetylase 6 interacts with the microtubule-associated protein tau. J Neurochem 106:2119-2130.
10. Ehlers CL, Li TK, Lumeng L, Hwang BH, Somes C, Jimenez P, Mathé AA (1998) Neuropeptide Y levels in ethanol-naïve alcohol-preferring and nonpreferring rats and in Wistar rats after ethanol exposure. Alcohol Clin Exp Res 22:1778-1782.
11. Enoch MA, Goldman D (2001) The genetics of alcoholism and alcohol abuse. Curr Psychiatry Rep 3:144-151.
12. File SE (1993) The interplay of learning and anxiety in the elevated plus-maze. Behav Brain Res 58:199-202.
13. Fukada M, Hanai A, Nakayama A, Suzuki T, Miyata N, Rodriguiz RM, Wetsel WC, Yao TP, Kawaguchi Y (2012) Loss of deacetylation activity of hdac6 affects emotional behavior in mice. PLoS one 7:e30924.
14. Gräff J, Rei D, Guan JS, Wang WY, Seo J, Hennig KM, Nieland TJ, Fass DM, Kao PF, Kahn M, Su SC, Samiei A, Joseph N, Haggarty SJ, Delalle I, Tsai LH (2012) An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature 483:222-226.
15. Gilpin NW, Badia-Elder NE, Elder RL, Stewart RB (2008) Schedule-induced polydipsia in lines of rats selectively bred for high and low ethanol preference. Behav Genet 38:515-524.
16. Gilpin NW, Henderson AN, Badia-Elder NE, Stewart RB (2011) Effects of neuropeptide Y and ethanol on arousal and anxiety-like behavior in alcohol-preferring rats. Alcohol 45:137-145.
17. Grayson DR, Kundakovic M, Sharma RP (2010) Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders? Mol Pharmacol 77:126-135.
18. Guan JS, Haggarty SJ, Giacometti E, Dannenberg JH, Joseph N, Gao J, Nieland TJ, Zhou Y, Wang X, Mazitschek R, Bradner JE, DePinho RA, Jaenisch R, Tsai LH (2009) HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459:55-60.
19. Heath AC, Bucholz KK, Madden PA, Dinwiddie SH, Slutske WS, Bierut LJ, Statham DJ, Dunne MP, Whitfield JB, Martin NG (1997) Genetic and environmental contributions to alcohol dependence risk in a national twin sample: consistency of findings in women and men. Psychol Med 27:1381-1396.
20. Heilig M (2004) The NPY system in stress, anxiety and depression. Neuropeptides 38:213-224.
21. Heilig M, Koob GF (2007) A key role for corticotropinreleasing factor in alcohol dependence. Trends Neurosci 30:399-406.
22. Hwang BH, Zhang JK, Ehlers CL, Lumeng L, Li TK (1999) Innate differences of neuropeptide Y (NPY) in hypothalamic nuclei and central nucleus of the amygdala between selectively bred rats with high and low alcohol preference. Alcohol Clin Exp Res 23:1023-1030.
23. Hwang BH, Suzuki R, Lumeng L, Li TK, McBride WJ (2004a) Innate differences in neuropeptide Y(NPY) mRNA expression in discrete brain regions between alcohol-preferring (P) and-nonpreferring (NP) rats: a significant low level of NPY mRNA in dentate gyrus of the hippocampus and absence of NPY mRNA in the medial habenular nucleus of P rats. Neuropeptides 38:359-368.
24. Hwang BH, Stewart R, Zhang JK, Lumeng L, Li TK (2004b) Corticotropin-releasing factor gene expression is down-regulated in the central nucleus of the amygdala of alcohol-preferring rats which exhibit high anxiety: a comparison between rat lines selectively bred for high and low alcohol preference. Brain Res 1026:143-150.
25. Jeanblanc J, He DY, Carnicella S, Kharazia V, Janak PH, Ron D (2009) Endogenous BDNF in the dorsolateral striatum gates alcohol drinking. J Neurosci 29:13494-13502.
26. Jenuwein T, Allis CD (2001) Translating the histone code. Science 293:1074-1080.
27. Kilgore M, Miller CA, Fass DM, Hennig KM, Haggarty SJ, Sweatt JD, Rumbaugh G (2010) Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease. Neuropsychopharmacology 35:870-880.
28. Konsoula Z, Barile FA (2012) Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders. J Pharmacol Toxicol Methods 66:215-220.
29. Koob GF (2003) Alcoholism: allostasis and beyond. Alcohol Clin Exp Res 27:232-243.
30. Koob GF, Volkow ND (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35:217-238.
31. Kushner MG, Abrams K, Borchardt C (2000) The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings. Clin Psychol Rev 20:149-171.
32. Li TK, Lumeng L, Doolittle DP (1993) Selective breeding for alcohol preference and associated responses. Behav Genet 23:163-170.
33. McBride WJ, Li TK (1998) Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents. Crit Rev Neurobiol 12:339-369.
34. McQuown SC, Barrett RM, Matheos DP, Post RJ, Rogge GA, Alenghat T, Mullican SE, Jones S, Rusche JR, Lazar MA, Wood MA (2011) HDAC3 is a critical negative regulator of long-term memory formation. J Neurosci 31:764-774.
35. Moberg CA, Curtin JJ (2009) Alcohol selectively reduces anxiety but not fear: startle response during unpredictable vs. predictable threat. J Abnorm Psychol 118:335-347.
36. Moonat S, Sakharkar AJ, Zhang H, Pandey SC (2011) The role of amygdaloid brain-derived neurotrophic factor, activity-regulated cytoskeleton-associated protein and dendritic spines in anxiety and alcoholism. Addict Biol 16:238-250.
37. Moonat S, Sakharkar AJ, Zhang H, Tang L, Pandey SC (2013) Aberrant histone deacetylase2-mediated histone modifications and synaptic plasticity in the amygdala predisposes to anxiety and alcoholism. Biol Psychiatry 73:763-773.
38. Murphy JM, Stewart RB, Bell RL, Badia-Elder NE, Carr LG, McBride WJ, Lumeng L, Li TK (2002) Phenotypic and genotypic characterization of the Indiana University rat lines selectively bred for high and low alcohol preference. Behav Genet 32:363-388.
39. Pandey SC (2003) Anxiety and alcohol abuse disorders: a common role for CREB and its target, the neuropeptide Y gene. Trends Pharmacol Sci 24:456-460.
40. Pandey SC, Carr LG, Heilig M, Ilveskoski E, Thiele TE (2003) Neuropeptide Y and alcoholism: genetic, molecular, and pharmacological evidence. Alcohol Clin Exp Res 27:149-154.
41. Pandey SC, Zhang H, Roy A, Xu T (2005) Deficits in amygdaloid cAMP-responsive element-binding protein signaling play a role in genetic predisposition to anxiety and alcoholism. J Clin Invest 115:2762-2773.
42. Pandey SC, Ugale R, Zhang H, Tang L, Prakash A (2008) Brain chromatin remodeling: a novel mechanism of alcoholism. J Neurosci 28:3729-3737.
43. Pascual M, Do Couto BR, Alfonso-Loeches S, Aguilar MA, Rodriguez-Arias M, Guerri C (2012) Changes in histone acetylation in the prefrontal cortex of ethanol-exposed adolescent rats are associated with ethanol-induced place conditioning. Neuropharmacology 62:2309-2319.
44. Renthal W, Nestler EJ (2008) Epigenetic mechanisms in drug addiction. Trends Mol Med 14:341-350.
45. Robison AJ, Nestler EJ (2011) Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci 12:623-637.
46. Robinson J, Sareen J, Cox BJ, Bolton J (2009) Self-medication of anxiety disorders with alcohol and drugs: results from a nationally representative sample. J Anxiety Disord 23:38-45.
47. Romieu P, Deschatrettes E, Host L, Gobaille S, Sandner G, Zwiller J (2011) The inhibition of histone deacetylases reduces the reinstatement of cocaine-seeking behavior in rats. Curr Neuropharmacol 9:21-25.
48. Sakharkar AJ, Zhang H, Tang L, Shi G, Pandey SC (2012) Histone deacetylases (HDAC)-induced histone modifications in the amygdala: a role in rapid tolerance to the anxiolytic effects of ethanol. Alcohol Clin Exp Res 36:61-71.
49. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101-1108.
50. Schuckit MA, Hesselbrock V (1994) Alcohol dependence and anxiety disorders: what is the relationship? Am J Psychiatry 151:1723-1734.
51. Spange S,Wagner T, Heinzel T, Krämer OH (2009) Acetylation of non-histone proteins modulates cellular signaling at multiple levels. Int J Biochem Cell Biol 41:185-198.
52. Spence JP, Liang T, Liu L, Johnson PL, Foroud T, Carr LG, Shekhar A (2009) From QTL to candidate gene: a genetic approach to alcoholism research. Curr Drug Abuse Rev 2:127-134.
53. Stewart RB, Gatto GJ, Lumeng L, Li TK, Murphy JM (1993) Comparison of alcohol-preferring (P) and non-preferring (NP) rats on tests of anxiety and for the anxiolytic effects of ethanol. Alcohol 10:1-10.
54. Suzuki R, Lumeng L, McBride WJ, Li TK, Hwang BH (2004) Reduced neuropeptide Y mRNA expression in the central nucleus of amygdala of alcohol preferring (P) rats: its potential involvement in alcohol preference and anxiety. Brain Res 1014:251-254.
55. Thiagalingam S, Cheng KH, Lee HJ, Mineva N, Thiagalingam A, Ponte JF (2003) Histone deacetylases: unique players in shaping the epigenetic histone code. Ann N Y Acad Sci 983:84-100.
56. Thiele TE, Badia-Elder NE (2003) A role for neuropeptide Y in alcohol intake control: evidence from human and animal research. Physiol Behav 79:95-101.
57. Tsankova N, Renthal W, Kumar A, Nestler EJ (2007) Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 8:355-367.
58. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ (2006) Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9:519-525.
59. Wang Y, Krishnan HR, Ghezzi A, Yin JC, Atkinson NS (2007) Drug-induced epigenetic changes produce drug tolerance. PLoS Biol 5:2342-2353.
60. Warnault V, Darcq E, Levine A, Barak S, Ron D (2013) Chromatin remodeling-a novel strategy to control excessive ethanol drinking. Transl Psychiatry 3:e231.
61. You C, Zhang H, Sakharkar AJ, Teppen T, Pandey SC (2013) Reversal of deficits in dendritic spines, BDNF, and Arc expression in the amygdala during alcohol dependence by HDAC inhibitor treatment. Int J Neuropsychopharmacol 17:313-322.
62. Zhang H, Sakharkar AJ, Shi G, Ugale R, Prakash A, Pandey SC (2010) Neuropeptide Y signaling in the central nucleus of amygdala regulates alcohol-drinking and anxiety-like behaviors of alcohol-preferring rats. Alcohol Clin Exp Res 34:451-461.